Trial intelligence / Profile preview

Chlorhexidine mouthwash for prevention of alveolar osteitis after tooth extraction

ISRCTN14646628Phase 4Completed

Sponsor
Universidad Austral de Chile
Start
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of chlorhexidine in alveolar osteitis (AO), sponsored by Universidad Austral de Chile. Primary endpoint: Primary outcome: alveolar osteitis diagnosis at 7 days. Started Apr 2013; status: completed.

02

Drugs

chlorhexidine
03

Conditions

alveolar osteitis (AO)

Beyond the preview

Go deeper on ISRCTN14646628.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN14646628.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call